Article Information
History
- November 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Juan Gómez1,8,12,*,
- Elías Cuesta-Llavona1,8,*,
- Guillermo M. Albaiceta2,8,9,10,11,
- Marta García-Clemente3,
- Carlos López-Larrea4,8,9,12,
- Laura Amado-Rodríguez2,8,10,11,
- Inés López-Alonso8,10,
- Tamara Hermida3,
- Ana I. EnrÍquez3,
- Helena Gil1,8,
- Belén Alonso1,8,
- Sara Iglesias1,8,
- Beatriz Suarez-Alvarez4,8,12,
- Victoria Alvarez1 and
- Eliecer Coto1,8,9,12,†
- 1Genética Molecular, Hospital Universitario Central Asturias, Oviedo, Spain
- 2Unidad de Cuidados Intensivos Cardiológicos, Hospital Universitario Central Asturias, Oviedo, Spain
- 3Neumología, Hospital Universitario Central Asturias, Oviedo, Spain
- 4Inmunología, Hospital Universitario Central Asturias, Oviedo, Spain
- 5Urgencias, Hospital Universitario Central Asturias, Oviedo, Spain
- 8Instituto de Investigación Sanitaria del Principado deAsturias, ISPA, Oviedo, Spain
- 9Universidad de Oviedo, Oviedo, Spain
- 10CIBER-Enfermedades Respiratorias. Instituto de Salud Carlos III. Madrid, Spain
- 11Instituto Universitario de Oncología del Principado de Asturias. Oviedo, Spain
- 12Red de Investigación Renal (REDINREN), Madrid, Spain
- ↵†Correspondenceto: Dr.EliecerCoto, Hospital Univ. Central Asturias, 33011 – Oviedo – Spain, Tel. 34.985.10.55.00, Email: eliecer.coto{at}sespa.es
↵* These authors contributed equally to this work.
Posted November 04, 2020.
The CCR5-delta32 variant might explain part of the association between COVID-19 and the chemokine-receptor gene cluster
